APA (7th ed.) Citation

Cox, T. M., Drelichman, G., Cravo, R., Balwani, M., Burrow, T. A., Martins, A. M., . . . Puga, A. C. (2015). Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: A phase 3, randomised, open-label, non-inferiority trial. Lancet, 385(9985), 2355. https://doi.org/10.1016/S0140-6736(14)61841-9

Chicago Style (17th ed.) Citation

Cox, Timothy M., et al. "Eliglustat Compared with Imiglucerase in Patients with Gaucher's Disease Type 1 Stabilised on Enzyme Replacement Therapy: A Phase 3, Randomised, Open-label, Non-inferiority Trial." Lancet 385, no. 9985 (2015): 2355. https://doi.org/10.1016/S0140-6736(14)61841-9.

MLA (9th ed.) Citation

Cox, Timothy M., et al. "Eliglustat Compared with Imiglucerase in Patients with Gaucher's Disease Type 1 Stabilised on Enzyme Replacement Therapy: A Phase 3, Randomised, Open-label, Non-inferiority Trial." Lancet, vol. 385, no. 9985, 2015, p. 2355, https://doi.org/10.1016/S0140-6736(14)61841-9.